MARK DEBUSSY, APRN
Psychiatric/Mental Health Nurse Practitioner in NEWARK, Delaware. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MARK DEBUSSY, APRN filed 346 Medicare Part D claims in 2023 across NEWARK, Delaware. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MARK DEBUSSY, APRN at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Delaware
How Psychiatric/Mental Health Nurse Practitioner compares to other specialties among Delaware providers
Psychiatric/Mental Health Nurse Practitioner share within Delaware
Psychiatric/Mental Health Nurse Practitioner is one of the more visible NUCC categories in Delaware
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Psychiatric/Mental Health Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Psychiatric/Mental Health Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Psychiatric/Mental Health Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Psychiatric/Mental Health Nurse Practitioner US NPIs
Specialty board-certified rate — Psychiatric/Mental Health Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK DEBUSSY, APRN is a Psychiatric/Mental Health Nurse Practitioner provider practicing in NEWARK, Delaware, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: APRN. NPI: 1407333164. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MARK DEBUSSY, APRN appears in the CMS NPPES registry as a Psychiatric/Mental Health Nurse Practitioner provider holding APRN credentials at 232 GOLDFINCH TURN, NEWARK, DE, 19711, with a listed phone of (302) 379-0899. NPI 1407333164 was issued on 07/25/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEBUSSY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 346 prescription claims written by this provider, covering 23 Medicare beneficiaries and totaling roughly $53K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Psychiatric/Mental Health Nurse Practitioner is a mid-sized specialty nationwide, with 39,953 enrolled providers across 54 states and an average of 927 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1407333164 |
|---|---|
| Specialty | Psychiatric/Mental Health Nurse Practitioner |
| Credentials | APRN |
| Gender | Male |
| NPI Issued | 07/25/2018 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK DEBUSSY, APRN's current license status, disciplinary history, and board certifications with the Delaware Board of Medical Licensure in Delaware before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Generic-heavy
3% brand-name claims vs 97% generic, on 346 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 707
- Total Day Supply
- 21,096
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $40K
- Generic Drug Cost
- $13K
Patient Demographics
- Average Patient Age
- 63.4 years
- Avg HCC Risk Score
- 1.06
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Bupropion Xl Bupropion Hcl | 33 |
| Aripiprazole | 27 |
| Escitalopram Oxalate | 22 |
| Fluoxetine Hcl | 22 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 21 |
| Alprazolam | 20 |
| Clonidine Hcl | 20 |
| Diazepam | 18 |
| Sertraline Hcl | 18 |
| Buspirone Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Psychiatric/Mental Health Nurse Practitioner Overview
How MARK DEBUSSY, APRN fits within the Psychiatric/Mental Health Nurse Practitioner landscape nationally.
MARK DEBUSSY, APRN's 346 claims are below the specialty average of 927.
Nearby Psychiatric/Mental Health Nurse Practitioner Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as DEBUSSY.
Compare Psychiatric/Mental Health Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Delaware
Frequently Asked Questions
What is MARK DEBUSSY, APRN's specialty? ▼
How much does MARK DEBUSSY, APRN prescribe under Medicare Part D? ▼
Where is MARK DEBUSSY, APRN located? ▼
What is MARK DEBUSSY, APRN's NPI number? ▼
Does MARK DEBUSSY, APRN prescribe more brand-name or generic drugs? ▼
How many Psychiatric/Mental Health Nurse Practitioner providers are there in the US? ▼
What drugs does MARK DEBUSSY, APRN prescribe most often? ▼
Does MARK DEBUSSY, APRN accept Medicare? ▼
How can I verify MARK DEBUSSY, APRN's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology